4,4'-Diaminodiphenylmethane


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000236 Adenoma PMID:3712494
MESH:D001649 Bile Duct Diseases PMID:26396155
MESH:D001660 Biliary Tract Diseases PMID:11289319; PMID:1440618
MESH:D001749 Urinary Bladder Neoplasms PMID:8074119
MESH:D002471 Cell Transformation, Neoplastic PMID:7505956
MESH:D002779 Cholestasis PMID:19486331; PMID:9022650
MESH:D003877 Dermatitis, Contact PMID:2952479; PMID:3621924
MESH:D005350 Fibroma PMID:6705139
MESH:D006042 Goiter PMID:7505956
MESH:D006505 Hepatitis PMID:6705139
MESH:D006529 Hepatomegaly PMID:28108177
MESH:D006965 Hyperplasia PMID:15034207; PMID:16005536; PMID:26396155
MESH:D006976 Hypertension, Pulmonary PMID:26116029
MESH:D007249 Inflammation PMID:26396155
MESH:D007565 Jaundice PMID:8074119; PMID:9022650
MESH:D007680 Kidney Neoplasms PMID:6582329
MESH:D008103 Liver Cirrhosis PMID:26396155
MESH:D008105 Liver Cirrhosis, Biliary PMID:15034207; PMID:9327722
MESH:D008106 Liver Cirrhosis, Experimental PMID:25380136
MESH:D008107 Liver Diseases PMID:26396155
MESH:D008113 Liver Neoplasms PMID:25058030; PMID:28108177
MESH:D008114 Liver Neoplasms, Experimental PMID:1399818; PMID:3712494; PMID:6587162
MESH:D009336 Necrosis PMID:26396155
MESH:D009436 Neural Tube Defects PMID:6679447
MESH:D009784 Occupational Diseases PMID:4026338; PMID:6482804
MESH:D009902 Optic Neuritis PMID:3988306
MESH:D010787 Photosensitivity Disorders PMID:6228378
MESH:D012162 Retinal Degeneration PMID:3692021
MESH:D013964 Thyroid Neoplasms PMID:1399818; PMID:3712494; PMID:6582329; PMID:6587162
MESH:D017449 Dermatitis, Allergic Contact PMID:11298694; PMID:11906362; PMID:12868966; PMID:14531868; PMID:18759878; PMID:2524372; PMID:8156756; PMID:8970840
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:11289319; PMID:1440618; PMID:16192314; PMID:18289764; PMID:18648102; PMID:18692083; PMID:30723492; PMID:6482804; PMID:6679447; PMID:7440962; PMID:8291058; PMID:9022650; PMID:9328219; PMID:9653073

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.